Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
23.93
+0.06 (0.25%)
Oct 21, 2026, 4:00 PM EDT - Market closed
Biodesix Market Cap
Biodesix has a market cap or net worth of $252.49 million as of October 21, 2026. It is the 19,297th most valuable company in the world and the 3,361st biggest in the United States. Its market cap has increased by 388.98% in one year.
Market Cap
252.49M
Enterprise Value
294.29M
1-Year Change
388.98%
Global Rank
Country Rank
#3,361 United States
Category
ChartMarket Cap Chart
Since October 28, 2020, Biodesix's market cap has decreased from $336.31M to $252.49M, a decrease of -24.92%. That is a compound annual growth rate of -4.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 252.49M | 366.72% |
| Dec 31, 2025 | 54.10M | -75.69% |
| Dec 31, 2024 | 222.56M | 33.69% |
| Dec 29, 2023 | 166.48M | -5.38% |
| Dec 30, 2022 | 175.94M | 23.06% |
| Dec 31, 2021 | 142.97M | -73.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Personalis | 1.70B |
| Freenome | 1.35B |
| OPKO Health | 1.21B |
| Castle Biosciences | 980.94M |
| Fulgent Genetics | 553.19M |
| Myriad Genetics | 403.64M |
| Exagen | 180.48M |
| Burning Rock Biotech | 127.61M |